Clincosm LogoSign in Get a demo

relapsed and refractory hematological malignancies

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and Refractory Hematological Malignancies Trial in Tianjin (CAR-T cells)

Available
  • Relapsed and Refractory Hematological Malignancies
  • CAR-T cells
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Feb 9, 2021